The Latest on: Gene patents
[google_news title=”” keyword=”gene patents” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Gene patents
- Patient dies in Pfizer study of Duchenne gene therapyon May 7, 2024 at 2:39 pm
Pfizer said the patient, a young boy who was treated earlier last year, had died suddenly. The company is working with trial researchers to investigate further.
- German Federal Patent Court Invalidates Patent Asserted By 10x Genomics, Delivering Legal Win to NanoString and Brukeron May 7, 2024 at 11:05 am
Bruker Corporation (Nasdaq: BRKR) today announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European Patent No. 2794928B1 (the ...
- Exclusive: Feng Zhang CRISPR startup gathers patents, locking up rights to family of editing techon May 7, 2024 at 4:00 am
In the bid to lock up patent rights to a growing suite of gene-editing technologies, Arbor Biotechnologies has acquired a small startup founded by MIT scientist and CRISPR pioneer Feng Zhang, the ...
- Court Grants Vizgen Motion to Expand Antitrust Case vs.10x, Harvardon May 6, 2024 at 4:59 pm
Vizgen cited as examples of anticompetitive activities what it called the unlawful bundling of 10x Genomics’ existing Chromium Single Cell Immune Profiling platform, and its Visium Spatial Gene ...
- Research team develops fast-track process for genetic improvement of plant traitson May 6, 2024 at 12:10 pm
Researchers interested in improving a given trait in plants can now identify the genes that regulate the trait's expression without doing any experiments.
- Livestock genome patent case rears head again with fresh court actionon April 30, 2024 at 11:05 pm
A long-running and controversial livestock genetics patent case has returned with five Australian industry groups including Meat & Livestock Australia now defending a new legal challenge in the ...
- Alnylam Pharmaceuticals gets grant for inhibiting expression of serum amyloid a geneon April 30, 2024 at 5:45 am
Discover the groundbreaking patent by Alnylam Pharmaceuticals Inc for a dsRNA molecule targeting Serum Amyloid A gene expression. Learn about the innovative design and potential applications in ...
- Cell and gene therapy companies trip at scalability hurdleon April 29, 2024 at 3:09 am
Experts hold scalability challenges and high costs accountable for market failures within the cell and gene therapy landscape.
- NxGen founder fires back at Penn and Dr. James Wilson in lawsuit over 'decade-long nightmare'on April 25, 2024 at 11:42 am
The one-time postdoctoral researcher alleges her "life’s work is being held hostage" by Penn and Dr. James Wilson, director of the university's gene therapy program.
via Bing News